Trial Information

Molecular Epidemiology of Acute Myelogenous Leukemia

INFORMED CONSENTS FOR AML PATIENTS:

For this study, you will be asked to complete a personal interview. During the interview,
you will be asked questions about your demographics (age, sex, etc.), any chemicals you may
have been exposed to, your medical history, family history of cancer, your diet, and your
smoking and alcohol use histories. It should take around 50 minutes to complete the
interview.

You will also have around 1 tablespoon of blood drawn for special tests. These tests will
look for any biologic factors associated with AML.

The interview and the blood draw may be done during a regularly scheduled visit to M. D.
Anderson, or may be scheduled at the time and place of your convenience.

You may be contacted at home by phone so that researchers can collect information about any
changes in your health status.

THIS IS AN INVESTIGATIONAL STUDY. Up to 1,200 participants will take part in this study.

INFORMED CONSENT FOR CONTROL SUBJECTS:

For this study, you will be asked to complete a personal interview. During the interview,
you will be asked questions about your demographics (age, sex, etc.), any chemicals you may
have been exposed to, your medical history, family history of cancer, your diet, and your
smoking and alcohol use histories. It should take around 50 minutes to complete the
interview.

You will also have around 1 tablespoon of blood drawn for special tests. These tests will
look for any biologic factors associated with AML. The interview and blood draw will be
scheduled at the time and place of your convenience.

THIS IS AN INVESTIGATIONAL STUDY. Up to 1,200 participants will take part in this study.